MedTrace Logo

Camelia Sinensis for Basal Metabolism and Body Composition

NCT05031702 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2022-03-03

No results posted yet for this study

Summary

Camellia Sinensis leaf extract contributes to increasing energy expenditure and calorie consumption by increasing thermogenesis. The purpose of this study is to evaluate the efficacy of Camellia Sinensis on basal metabolism and body composition in overweight women or with obesity in postmenopause.

Conditions

  • Postmenopausal Disorder

Interventions

DIETARY_SUPPLEMENT

Camellia Sinensis leaf extract

2 tablets per day of 150 mg (1 before lunch and 1 before dinner)

COMBINATION_PRODUCT

Placebo

2 tablets per day of 150 mg (1 before lunch and 1 before dinner)

Sponsors & Collaborators

  • Azienda di Servizi alla Persona di Pavia

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-08
Primary Completion
2022-01-03
Completion
2022-07-25

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05031702 on ClinicalTrials.gov